Finding schizophrenia genes

Journal of Clinical Investigation

Volumn 115, Issue 6, 2005, Pages 1440-1448

  Kirov, George ^a   O'Donovan, Michael C ^a   Owen, Michael J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; CHROMOSOME ABERRATION; DISEASE PREDISPOSITION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; HUMAN; LINKAGE ANALYSIS; MOLECULAR GENETICS; NEUROBIOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; EPIDEMIOLOGY, MOLECULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); SCHIZOPHRENIA;

EID: 20444471919     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI24759     Document Type: Review

References (125)

1. McGrath, J., et al. 2004. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2:13.
2. McGuffin, P., Owen, M.J., O'Donovan, M.C., Thapar, A., and Gottesman, I.I. 1994. Schizophrenia. In Seminars in psychiatric genetics, Royal College of Psychiatrists. London, United Kingdom, 87-109.
3. Gottesman, I.I. 1991. Schizophrenia genesis: the origins of madness. Henry Holt & Company Inc. New York, New York, USA. 296 pp.
4. Riley, B.C., and Kendler, K.S. 2004. Schizophrenia: genetics. In Kaplan and Sadock's comprehensive textbook psychiatry. 8th edition. B.J. Sadock and V.A. Sadock, editors. Lippincott Williams and Wilkins. Philadelphia, Pennsylvania, USA. 1354-1371.
5. Cardno, A.G., and Gottesman, I.I. 2000. Twin studies of schizophrenia: from bow-and-atrow concordances to star war Mx and functional genomics. Am. J. Med.Genet. 97:12-17.
6. Kyvik, K.O., Green, A., and Beck-Nielsen, H. 1995. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ. 311:913-917.
7. Hyttinen, V., Kaprio, J., Kinnunen, L., Koskenvuo, M., and Tuomilehto, J. 2003. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes. 52:1052-1055.
8. Locatelli, I., Lichtenstein, P., and Yashin, A.I. 2004. The heritability of breast cancer: a bayesian correlated frailty model applied to Swedish twins data. Twin Res. 7:182-191.
9. Zdravkovic, S., et al. 2002. Heritabiiity of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J. Intern. Med. 252:247-254.
10. Poulsen, P., Kyvik, K.O., Vaag, A., and Beck-Nielsen, H. 1999. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia. 42:139-145.
11. Gottesman, I.I., and Shields, J. 1967. A polygenic theory of schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 58:199-205.
12. McGue, M., and Gottesman, I.I. 1989. A single dominant gene still cannot account for the transmission of schizophrenia. Arch. Gen. Psychiatry. 46:478-480.
13. Risch, N. 1990. Genetic linkage and complex diseases, with special reference to psychiatric disorders [review]. Genet. Epidemiol. 7:3-16; discussion 17-45.
14. Gottesman, I.I., and Shields, J. 1982. Schizophrenia: the epigenetic puzzle. Cambridge University Press. Cambridge, United Kingdom. 258 pp.
15. Farmer, A.E., McGuffin, P., and Gottesman I.I. 1987. Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition. Arch. Gen. Psychiatry. 44:634-641.
16. Kendler, K.S., Neale, M.C., and Walsh, D. 1995. Evaluating the spectrum concept of schizophrenia in the Roscommon Family Study. Am. J. Psychiatry. 152:749-754.
17. Kendler, K.S., Karkowski, L.M., and Walsh, D. 1998. The structure of psychosis: latent class analysis of probands from the Roscommon Family Study. Arch. Gen. Psychiatry. 55:492-499.
18. Tienari, P. et al. 2000. Finnish adoptive family study: sample selection and adoptee DSM-III-R diagnoses. Acta Psychiatr. Scand. 101:433-443.
19. Murray, R.M., Jones, P.B., Susser, E., van Os, J., and Cannon, M. 2002. The epidemiology of schizophrenia. Cambridge University Press. Cambridge, United Kingdom, 454 pp.
20. Seeman, P., and Lee, T. 1975. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science. 188:1217-1219.
21. Abi-Dargham, A., et al. 2000. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 97:8104-8109.
22. Weinberger, D.R., et al. 2001. Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry. 50:825-844.
23. Meltzer, H.Y., Matsubara, S., and Lee, J.C. 1989. Classification of typical and atypical: antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J. Pharmacol. Exp. Ther. 251:238-246.
24. Javitc, D.C., and Zukin, S.R. 1991. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1301-1308.
25. Laruelle, M., Kegeles, L.S., and Abi-Dargham, A. 2003. Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann. N. Y. Acad. Sci. 1003:138-158.
26. Weinberger, D.R. 1995. From neuropathology to neurodevelopment. Lancet. 346:552-557.
27. Murray, R.M., and Lewis, S.W. 1987. Is schizophrenia a neurodevelopmental disorder? Br. Med. J. 295:681-682.
28. Pantelis, C., et al. 2003. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRJ comparison. Lancet. 361:281-288.
29. Lawrie, S.M., et al. 1999. Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet. 353:30-33.
30. Harrison, P.J. 1999. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 122:593-624.
31. Davis, K.L., et al. 2003. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch. Gen. Psychiatry. 60:443-456.
32. Suarez, B.K., Hampe, C.L., and Van Eerdewegh, P. 1994. Problems of replicating linkage claims in psychiatry. In Genetic approaches to mental disorders. E.S. Gershon and C.R. Cloninger, editors. American Psychiatric Press. Washington, DC, USA. 23-46.
33. Lander, E., and Kruglyak, L. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11:241-247.
34. Brzustowicz, L.M., Hodgkinson, K.A., Chow, E.W., Honer, W.G., and Bassett, A.S. 2000. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science. 288:678-682.
35. Ekelund, J., et al. 2001. Chromosome 1 loci in Finnish schizophrenia families. Hum. Mol. Genet. 10:1611-1617.
36. Blackwood, D.H., et al. 2001. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet. 69:428-433.
37. Ekelund, J., et al. 2004. Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol. Psychiatry. 9:1037-1041.
38. Gurling, H.M., et al. 2001. Genomewide generic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32 2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am. J. Hum. Genet. 68:661-673.
39. Straub, R.E., MacLean, C.J., O'Neil, F.A., Walsh, D., and Kendler, K.S. 1997. Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol. Psychiatry. 2:148-155.
40. Devlin, B., et al. 2002. Genome-wide multipoint linkage analyses of multiplex schizophrenia pedigrees from the oceanic nation of Palau. Mol. Psychiatry. 7:689-694.
41. Paunio, T., et al. 2001. Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum. Mol. Genet. 10:3037-3048.
42. Straub, R.E., et al. 1995. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat. Genet. 11:287-293.
43. Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6, and 8. 1996. Additional support for schizophrenia linkage on chromosomes 6 and 8: a muiticenter study. Am. J. Med. Genet. 67:580-594.
44. Maziade, M., Bissonnette, L., Rouillard, E., Roy, M.A., and Merette, C. 1997. Further evidence of a susceptibility gene for schizophrenia in 6p22-p24: a contribution from the eastern Quebec population. Am. J. Med. Genet. 74:666-667.
45. Schwab, S.G., et al. 2000. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol. Psychiatry. 5:638-649.
46. Martinez, M., et al. 1999. Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q. Am. J. Med. Genet. 88:337-343.
47. Lindholm, E. et al. 2001. A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. Am. J. Hum. Genet. 69:96-105.
48. Lerer, B., et al. 2003. Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Mol. Psychiatry. 8:488-498.
49. Blouin, J.L., et al. 1998. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat. Genet. 20:70-73.
50. Stefansson, H., et al. 2002. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71:877-892.
51. DeLisi, L.E., et al. 2002. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am. J. Psychiatry. 159:803-812.
52. Fallin, M.D., et al. 2003. Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22. Am. J. Hum. Genet. 73:601-611.
53. Williams, N., et al. 2003. A systematic genomewide linkage study in 353 sib pairs with schizophrenia. Am. J. Hum. Genet. 73:1355-1367.
54. Brzustowicz, L.M., et al. 1999. Linkage of familial schizophrenia to chromosome 13q32. Am. J. Hum. Genet. 65:1096-1103.
55. Badner, J.A., and Gershon, E.S. 2002. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol. Psychiatry. 7:405-411.
56. Lewis, C.M., et al. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am. J. Hum. Genet. 73:34-48.
57. Gottesman, I.I., and Gould, T.D. 2003. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry. 160:636-645.
58. Straub, R.E., et al. 2002. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 71:337-348.
59. Schwab, S.G., et al. 2003. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet. 72:185-190.
60. Williams, N.M., et al. 2004. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch. Gen. Psychiatry. 61:336-344.
61. Kirov, G., et al. 2004. Strong evidence for association between the dystrobrevin binding protein 1 (DTNBP1) gene and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol. Psychiatry. 55:971-975.
62. Van Den Bogaert, A., et al. 2003. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am. J. Hum. Genet. 73:1438-1443.
63. Morris, D.W., et al. 2003. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study. Schizophr. Res. 60:167-172.
64. Numakawa, T., et al. 2004. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet. 13:2699-2708.
65. Funke, B., et al. 2004. Association of the DTNBP1 locus with schizophrenia in a U.S. Population. Am. J. Hum. Genet. 75:891-898.
66. Bray, N.J., Buckland, P.R., Owen, M.J., and O'Donovan, M.C. 2003. Cis-acting variation in the expression of a high proportion of genes in human brain. Hum. Genet. 113:149-153.
67. Weickert, C.S., et al. 2004. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch. Gen. Psychiatry. 61:544-555.
68. Talbot, K., et al. 2004. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest. 113:1353-1363. doi:10.1172/JCI200420425.
69. Stefansson, H., et al. 2003. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am. J. Hum. Genet. 72:83-87.
70. Williams, N.M., et al. 2003. Support for generic variation in neuregulin 1 and susceptibility to schizophrenia. Mol. Psychiatry. 8:485-487.
71. Corvin, A.P., et al. 2004. Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the neuregulin-1 locus. Mol. Psychiatry. 9:208-213.
72. Yang, J.Z., et al. 2003. Association study of neuregulin 1 gene with schizophrenia. Mol. Psychiatry. 8:706-709.
73. Tang, J.X., et al. 2004. Polymorphisms within 5′ end of the neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol. Psychiatry. 9:11-12.
74. Zhao, X., et al. 2004. A case control and family based association study of the neuregulin1 gene and schizophrenia. J. Med. Genet. 41:31-34.
75. Li, T., et al. 2004. Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Mol. Psychiatry. 9:698-704.
76. Hall, D., Gogos, J.A., and Karayiorgou, M. 2004. The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav. 3:240-248.
77. Iwata, N., et al. 2004. No association with the neuregulin 1 haplotype to Japanese schizophrenia. Mol. Psychiatry. 9:126-127.
78. Thiselton, D.L., et al. 2004. No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF). Mol. Psychiatry. 9:777-783.
79. Hong, C.J., et al. 2004. Case-control and family-based association studies between the neuregulin 1 (Arg38Gln) polymorphism and schizophrenia. Neurosci. Lett. 366:158-161.
80. Stefansson, H., Steinthorsdottir, V., Thorgeirsson, T.E., Gulcher, J.R., and Stefansson, K. 2004. Neuregulin 1 and schizophrenia. Ann. Med. 36:62-71.
81. Hashimoto, R., et al. 2004. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol. Psychiatry. 9:299-307.
82. Corfas, G., Roy, K., and Buxbaum, J.D. 2004. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat. Neurosci. 7:575-580.
83. Chumakov, I., et al. 2002. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 99:13675-13680.
84. Schumacher, J., et al. 2004. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol. Psychiatry. 9:203-207.
85. Wang, X., et al. 2004. Association of G72/G30 with schizophrenia in the Chinese population. Biochem. Biophys. Res. Commun. 319:1281-1286.
86. Addingron, A.M., et al. 2004. Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol. Psychiatry. 55:976-980.
87. Chowdari, K.V., et al. 2002. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 11:1373-1380.
88. Williams, N.M., et al. 2004. Support for RGS4 as a susceptibility gene for schizophrenia. Biol. Psychiatry. 55:192-195.
89. Chen, X., et al. 2004. Regulator of G-procein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am. J. Med. Genet. B Neuropsychiatr. Genet. 129B:23-26.
90. Morris, D.W., et al. 2004. Confirming RGS4 as a susceptibility gene for schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 125B:50-53.
91. Beyer, C.E., et al. 2004. Regulators of G-protein signaling 4: modulation of 5-HT(1A)-mediated neurotransmitter release in vivo. Brain Res. 1022:214-220.
92. De Blasi, A., Conn, P.J., Pin, J., and Nicoletti, F. 2001. Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol. Sci. 22:114-120.
93. Taymans, J.M., et al. 2004. Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time. Eur. J. Neurosci. 19:2249-2260.
94. Thaminy, S., Auerbach, D., Arnoldo, A., and Stagljar, I. 2003. Identification of novel ErbB3-interacting factors using the split-ubiquitin membrane yeast two-hybrid system. Genome Res. 13:1744-1753.
95. Brzustowicz, L.M., et al. 2004. Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. Am. J. Hum. Genet. 74:1057-1063.
96. Gerber, D.J., et al. 2003. Evidence for association of schizophrenia with genetic variation in the Sp21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc. Natl. Acad. Sci. U. S. A. 100:8993-8998.
97. Duan, J., et al. 2004. Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am. J. Hum. Genet. 75:624-638.
98. MacIntyre, D.J., Blackwood, D.H., Porteous, D.J., Pickard, B.S., and Muir, W.J. 2003. Chromosomal abnormalities and mental illness. Mol. Psychiatry. 8:275-287.
99. Pulver, A.E., et al. 1994. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J. Nerv. Ment. Dis. 182:476-478.
100. Bassett, A.S., et al. 1998. 22q11 deletion syndrome in adults with schizophrenia. Am. J. Med. Genet. 81:328-337.
101. Murphy, K.C., Jones, L.A., and Owen, M.J. 1999. High rates of schizophrenia in adults with velocardio-facial syndrome. Arch. Gen. Psychiatry. 56:940-945.
102. Ivanov, D., et al. 2003. A molecular genetic study of the vcfs region in patients with early onset psychosis. Br. J. Psychiatry. 183:409-413.
103. Shaikh, T.H., et al. 2000. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organisation and deletion endpoint analysis. Hum. Mol. Genet. 9:489-501.
104. Chen, X., Wang, X., O'Neill, A.F., Walsh, D., and Kendler, K.S. 2004. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol. Psychiatry. 9:962-967.
105. Egan, M.F., et al. 2001. Effect of COMT Vall08/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98:6917-6922.
106. Malhotra, A.K., et al. 2002. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry. 159:652-654.
107. Glatt, S.J., Faraone, S.V., and Tsuang, M.T. 2003. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am. J. Psychiatry. 160:469-476.
108. Shifman, S., et al. 2002. A highly significant association between a comt haplotype and schizophrenia. Am. J. Hum. Genet. 71:1296-1302.
109. Li, T., et al. 2000. Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol. Psychiatry. 5:77-84.
110. Williams, H., et al. 2005. No association between polymorphisms in COMT and schizophrenia in two large samples. Am. J. Psychiatry. In press.
111. Sanders, A.R., et al. 2005. Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia. Mol. Psychiatry. 10:353-365.
112. Bray, N.J., et al. 2003. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am. J. Hum. Genet. 73:152-161.
113. Gogos, J.A., et al. 1999. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat. Genet. 21:434-439.
114. Jacquet, H., et al. 2002. PRODH mutations and hyperprolinemia in a subset of schizophrenic patients. Hum. Mol. Genet. 11:2243-2249.
115. Liu, H., et al. 2002. Genetic variation at the 22q11 PRODH/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 99:3717-3722.
116. Li, T., et al. 2004. Evidence for association between novel polymorphisms in the PRODH gene and schizophrenia in a Chinese population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 129B:13-15.
117. Williams, H.J., et al. 2003. Association between PRODH and schizophrenia is not confirmed. Mol. Psychiatry. 8:644-645.
118. Ohtsuki, T., et al. 2004. Failure to find association between PRODH deletion and schizophrenia. Schizophr. Res. 67:111-113.
119. Mukai, J., et al. 2004. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat. Genet. 36:725-731.
120. Chen, W.Y., et al. 2004. Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8. Hum. Mol. Genet. 13:2991-2995.
121. MilIar, J.K., et al. 2000. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9:1415-1423.
122. Miyoshi, K., et al. 2003. Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol. Psychiatry. 8:685-694.
123. Ozeki, Y, et al. 2003. Disrupted-in-schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 100:289-294.
124. Devon, R.S., et al. 2001. Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar disorder. Psychiatr. Genet. 11:71-78.
125. Kockelhorn, T.T., et al. 2004. Association study of polymorphisms in the 5′ upstream region of human DISC1 gene with schizophrenia. Neurosci. Lett. 368:41-45.